Description

RZiDiNE-A Injection combines the proven efficacy of Ceftazidime and Avibactam to deliver targeted, high-impact treatment against resistant Gram-negative infections.

⚡ Fighting Infection with Strength & Precision

• Advanced combination designed for multi-drug-resistant pathogens
• Effective against ESBL-producing Enterobacterales
• Active against carbapenem-resistant Enterobacterales (CRE)
• Strong coverage for Pseudomonas aeruginosa infections

🔬 Dual Mechanism Advantage

Ceftazidime

• Broad-spectrum cephalosporin with potent Gram-negative activity

Avibactam

• Novel β-lactamase inhibitor
• Protects ceftazidime from enzymatic degradation
• Restores activity against resistant organisms

🏥 Clinical Indications

• Complicated Intra-abdominal Infections (cIAI)
• Complicated Urinary Tract Infections (cUTI), including kidney infections
• Hospital-Acquired Pneumonia (HAP)
• Ventilator-Associated Pneumonia (VAP)

💡 Why RZiDiNE-A?

• Effective in difficult-to-treat infections
• Designed for critical care and hospital use
• Helps combat antibiotic resistance with precision therapy

RZiDiNE-A – Precision Power Against Resistant Infections.